Lipocine Inc. (LPCN) Financials
LPCN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 25.4 million | 2.5 million |
| Dec. 31, 2025 | 17.0 million | 2.5 million |
| Sept. 30, 2025 | 16.1 million | 1.9 million |
| June 30, 2025 | 18.6 million | 1.4 million |
LPCN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -2.3 million | ? |
| Dec. 31, 2025 | -2.9 million | 53032 |
| Sept. 30, 2025 | -3.0 million | 53256 |
| June 30, 2025 | -1.9 million | 65205 |
LPCN Net Income
No data available :(
LPCN Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 24.7 million | - | - |
| Dec. 31, 2025 | 14.9 million | - | - |
| Sept. 30, 2025 | 15.1 million | - | - |
| June 30, 2025 | 17.9 million | - | - |
LPCN Shares Outstanding
LPCN Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 3 | 2.8 million | 1.2 million | - |
| Dec. 31, 2025 | 3 | 2.7 million | 983390 | - |
| Sept. 30, 2025 | 3 | 2.7 million | 767837 | - |
| June 30, 2025 | 4 | 2.1 million | 890433 | - |
LPCN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 119397 | 14814 |
| Dec. 31, 2025 | 1.1 million | 14981 |
| Sept. 30, 2025 | 114574 | - |
| June 30, 2025 | 622849 | 2.1 million |
LPCN Revenue by Segment
Graph available only for paid members. Upgrade to see it.
LPCN
Price: $2.33
52 week price:
Earnings Per Share: -1.96 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 27881
Ebitda: -4.8 millionMarket Capitalization: 12.8 million